Elite Pharmaceuticals ELTP
OTC ELTP
$0.24 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:00 AM EDT

Elite Pharmaceuticals (ELTP) Operating Income (2010 - 2026)

Updated

Elite Pharmaceuticals (ELTP) reported Operating Income of $7.53 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 65.3% from $21.7 million a year earlier and down 26.1% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Operating Income (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Elite Pharmaceuticals' Operating Income came in at $34.94 million, down 6.7% year-over-year; for FY2026 (ended Mar 31, 2026), it was $49.11 million, up 150.6% from FY2025.

  • Operating Income has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 87.8% (FY2021 to FY2026).
  • By fiscal year, Operating Income came in at $19.6 million in FY2025 (+81.7%), $10.79 million in FY2024 (+193.5%), $3.68 million in FY2023 (-27.5%) and $5.07 million in FY2022 (+140.9%).
  • The fiscal Q1 2027 figure ranks as the lowest quarterly Operating Income since fiscal Q3 2025.
  • Year over year, Operating Income gained in five of the last eight quarters, with growth averaging 181.9%.
  • The high point for year-over-year Operating Income in five years was fiscal Q3 2026 (growth of 721.0%); the low point was fiscal Q3 2025 (a decline of 68.9%).
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $10.19 million (Q4 2026), $9.01 million (Q3 2026) and $8.21 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn 7.14 Bn
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn 6.43 Bn
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn 3.16 Bn
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn -10.39 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 4.27 Bn
10 Elite Pharmaceuticals 262.85 Mn 144.52 Mn 13.51 Mn 7.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.53 Mn
Mar 31, 2026 10.19 Mn
Dec 31, 2025 9.01 Mn
Sep 30, 2025 8.21 Mn
Jun 30, 2025 21.70 Mn
Mar 31, 2025 11.15 Mn
Dec 31, 2024 1.10 Mn
Sep 30, 2024 3.48 Mn
Jun 30, 2024 3.86 Mn
Mar 31, 2024 3.73 Mn
Dec 31, 2023 3.53 Mn
Sep 30, 2023 1.93 Mn
Jun 30, 2023 1.60 Mn
Mar 31, 2023 -386,899.00
Dec 31, 2022 1.96 Mn
Sep 30, 2022 1.08 Mn
Jun 30, 2022 1.02 Mn
Mar 31, 2022 851,676.00
Dec 31, 2021 1.83 Mn
Sep 30, 2021 1.42 Mn
API Access

Elite Pharmaceuticals Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=ELTP&period=max&api_key=YOUR_API_KEY